Tag: Marc Voigt
Immutep gets green light for large-scale cancer product manufacturing for clinical trials
Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use.Â
Featured Article
Future-ready manufacturing: How AI and cloud ERP are transforming supply chains
As manufacturers face growing supply chain disruption, rising costs and increasing operational complexity, artificial intelligence (AI), cloud ERP and connected digital systems are becoming essential tools for improving visibility, resilience and decision-making.
